# Cresco Labs Inc.: financial statements, quarterly

CRLBF · OTC · CIK 1832928 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crlbf.md) · [Financials](/companies/crlbf/financials.md) · [Filings](/companies/crlbf/filings.md) · [Insiders](/companies/crlbf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/crlbf/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2018-12-31) | period not labelled (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [49.1](/filings/0001193125-21-140825.md) | [136](/filings/0001193125-22-096315.md) | [224](/filings/0001832928-23-000003.md) | [119](/filings/0001832928-24-000024.md) | [103](/filings/0001832928-25-000006.md) | [138](/filings/0001832928-26-000005.md) | [57.9](/filings/0001832928-26-000005.md) |
| Current assets | $m | not reported | [159](/filings/0001193125-21-140825.md) | [249](/filings/0001193125-22-096315.md) | [422](/filings/0001832928-23-000003.md) | [326](/filings/0001832928-24-000024.md) | [278](/filings/0001832928-25-000006.md) | [294](/filings/0001832928-26-000005.md) | [259](/filings/0001832928-26-000005.md) |
| Total assets | $m | not reported | [617](/filings/0001193125-21-140825.md) | [1,233](/filings/0001193125-22-096315.md) | [1,780](/filings/0001832928-23-000003.md) | [1,584](/filings/0001832928-24-000024.md) | [1,358](/filings/0001832928-25-000006.md) | [1,355](/filings/0001832928-26-000005.md) | [1,197](/filings/0001832928-26-000005.md) |
| Current liabilities | $m | not reported | [150](/filings/0001193125-21-140825.md) | [253](/filings/0001193125-22-096315.md) | [288](/filings/0001832928-23-000003.md) | [256](/filings/0001832928-24-000024.md) | [200](/filings/0001832928-25-000006.md) | [94.3](/filings/0001832928-26-000005.md) | [100](/filings/0001832928-26-000005.md) |
| Total liabilities | $m | not reported | [294](/filings/0001193125-21-140825.md) | [657](/filings/0001193125-22-096315.md) | [983](/filings/0001832928-23-000003.md) | [996](/filings/0001832928-24-000024.md) | [930](/filings/0001832928-25-000006.md) | [967](/filings/0001832928-26-000005.md) | [945](/filings/0001832928-26-000005.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [498](/filings/0001832928-25-000006.md) | [461](/filings/0001832928-26-000005.md) | [417](/filings/0001832928-26-000005.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [2.0](/filings/0001832928-25-000006.md) | [2.6](/filings/0001832928-26-000005.md) | [3.3](/filings/0001832928-26-000005.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [11.8](/filings/0001832928-25-000006.md) | [11.9](/filings/0001832928-26-000005.md) | [10.8](/filings/0001832928-26-000005.md) |
| Shareholders' equity | $m | [283](/filings/0001193125-21-140825.md) | [187](/filings/0001193125-21-140825.md) | [473](/filings/0001193125-22-096315.md) | [756](/filings/0001832928-23-000003.md) | [588](/filings/0001832928-25-000006.md) | [506](/filings/0001832928-25-000006.md) | [475](/filings/0001832928-26-000005.md) | [340](/filings/0001832928-26-000005.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: ifrs-full:CurrentAssets, us-gaap:AssetsCurrent
- Total assets: ifrs-full:Assets, us-gaap:Assets
- Current liabilities: ifrs-full:CurrentLiabilities, us-gaap:LiabilitiesCurrent
- Total liabilities: ifrs-full:Liabilities, us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.